Day: February 10, 2025

This news release constitutes a “designated news release” for the purposes of CAPREIT’s prospectus supplement dated February 22, 2024, to its short form base shelf prospectus dated May 9, 2023. TORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today that it has completed two non-core dispositions in Canada for combined gross proceeds of $96.8 million, in addition to closing on the previously announced 717-suite sale in Montréal for $103.8 million. CAPREIT also announced that it has acquired two recently constructed rental apartment properties in Western Canada for an aggregate purchase price of $97.6 million. All amounts disclosed herein exclude transaction costs and other customary adjustments. In January, CAPREIT sold a non-core portfolio containing...

PASADENA, CALIF., Feb. 10, 2025 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that it has filed a request for withdrawal with the Securities and Exchange Commission (the “SEC”) of the Company’s Registration Statement on Form S-1 (No. 333-282781), as amended, originally filed on October 23, 2024 (the “Registration Statement”), as the Company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the offering described in the Registration Statement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Company’s...

Posts Strong Sequential Improvement in Adjusted EBITDA CINCINNATI, Feb. 10, 2025 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal year 2025 financial results and operational highlights. These results pertain to the three months ended December 31, 2024 and are reported in U.S. Dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, February 11, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (844) 763-8274 or 1 (647) 484-8814. A live webcast of the call will be accessible via the Company’s website at https://quipthomemedical.com/investors/events-presentations/, which will be available on the Company’s...

MIAMI, Feb. 10, 2025 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America’s largest Bitcoin miners, today announced it will release financial results for the full year of 2024 before the market opens on March 3, 2025. The Company will host a conference call and webcast to review the results on the same day at 8:30 a.m. ET. Conference Call and Webcast Details Date: Monday, March 3, 2025Time: 8:30 a.m. ET Investors can join the live webcast here. Analysts can register here. Supplemental Materials and Upcoming Communications The Company expects to make available on its website materials designed to accompany the discussion of its results, along with certain supplemental financial information and other data....

CHICAGO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the fourth quarter and fiscal year ended December 31, 2024, before the market opens on Thursday, February 27, 2025. A conference call and webcast with analysts and investors is scheduled for Thursday, February 27, 2025 at 8:30 a.m. ET / 7:30 a.m. CT to discuss the results and answer investor and participant questions.Investors and participants can register in advance for the call by visiting:https://register.vevent.com/register/BI52d3575dc26a4925a98967014fdd307fAfter registering, instructions will be shared on how to join the call for those who wish to dial in. On February 27, 2025, the live webcast...

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today announced that Martin Babler, President and Chief Executive Officer of Alumis, will present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025 at 3:20 pm ET. A live webcast will be available on the Alumis website in the “Investors” section under the “Events” page. About Alumis Alumis is a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated...

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 105,100 shares of its common stock and granted an aggregate of 9,950 restricted stock unit (“RSU”) awards to 14 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4). The 2021 Inducement Plan is used exclusively for granting equity awards to individuals who were not previously employees of Crinetics,...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) announced today that it has agreed to offer, on a private placement basis in each of the provinces and territories of Canada (the “Offering”), $450 million aggregate principal amount of series K senior unsecured debentures that will bear interest at a rate of 4.808% per annum and will mature on February 24, 2029 (the “Debentures”). The Debentures will be issued under Allied’s Green Financing Framework (the “Framework”), which is available on Allied’s website at https://www.alliedreit.com/company/esg/. The Debentures will be sold at par with a yield of 4.808% per annum, and are being offered on an agency basis by a syndicate...